c-Targeted Gene Editing for Cancer Immunotherapy
Università degli Studi di Perugia invites applications for a Research Fellow to advance gene-targeting and genome-editing strategies aimed at selectively modulating conventional type 1 dendritic cells (cDC1) in cancer immunotherapy.
The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in cDC1, with analyses by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.
The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in cDC1, with analyses by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.